The BioPharm Brief: FDA Decisions, Vaccine Momentum, and Lymphoma Advances

Jun 18, 10:15 PM
Headliner
Share
Subscribe

Today's BioPharm Brief covers an FDA filing acceptance for Roche's Lunsumio and Polivy combination in lymphoma, a pediatric expansion for Merck's CAPVAXIVE vaccine, and a key advisory committee meeting for Moderna's mRNA-based flu vaccine.

Share
Subscribe
Next
The BioPharm Brief: Triple Threats, TL1A Bets, and AI Brains
Top episodes
The BioPharm Brief: Early Design Risks, Oncology Signals, and a Biosimilars Power Move
by The BioPharm Brief
The BioPharm Brief: Cancer, Personalized
by The BioPharm Brief
The BioPharm Brief: What’s the Big Deal About Multispecific T-Cell Engagers in Cancer and Autoimmune Diseases?
by The BioPharm Brief